From: Estimating the survival advantage based on telomere length and serum biomarkers of aging
Group
Age (\( {\bar{\text{x}}} \))
I (%)
II (%)
III (%)
IV (%)
χ 2
p
Diabetes
65.19
25.0
10.0
27.5
37.5
2.862
0.413
Control
63.12
35
16.7
18.3
30.0